Globus Medical Inc (GMED)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 537,868 | 102,984 | 122,873 | 190,169 | 149,191 |
| Depreciation Amortization | 302,954 | 495,439 | 225,358 | 73,641 | 72,648 |
| Income taxes - deferred | 18,625 | -125,902 | -57,789 | -22,223 | -17,615 |
| Accounts receivable | -52,182 | -78,062 | -49,914 | -50,843 | -25,895 |
| Accounts payable and accrued liabilities | 8,487 | 17,663 | -14,223 | 14,418 | 3,684 |
| Other Working Capital | -66,795 | -97,554 | -116,598 | -105,262 | -17,252 |
| Other Operating Activity | 4,490 | 206,070 | 133,792 | 78,568 | 111,513 |
| Operating Cash Flow | $753,447 | $520,638 | $243,499 | $178,468 | $276,274 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 179,488 | 70,517 | 777,913 | 414,654 | 337,806 |
| PPE Investments | -164,679 | -115,429 | -78,274 | -74,047 | -56,898 |
| Net Acquisitions | -252,546 | -17,635 | -296,028 | -31,435 | -34,488 |
| Purchase Of Investment | -107,531 | -113,504 | -100,643 | -419,534 | -622,359 |
| Purchase Sale Intangibles | -9,746 | 0 | 0 | N/A | N/A |
| Other Investing Activity | -9,746 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-355,014 | $-176,051 | $302,968 | $-110,362 | $-375,939 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 89,757 | 110,439 | 12,397 | 41,716 | 63,496 |
| Common Stock Repurchased | -300,451 | -85,787 | -225,562 | -144,493 | N/A |
| Other Financing Activity | -468,466 | -52,348 | -18,656 | -7,185 | -9,349 |
| Financing Cash Flow | $-679,160 | $-27,696 | $-231,821 | $-109,962 | $54,147 |
| Exchange Rate Effect | 22,445 | 255 | 2,180 | -747 | -810 |
| Beginning Cash Position | 784,438 | 467,292 | 150,466 | 193,069 | 239,397 |
| End Cash Position | 526,156 | 784,438 | 467,292 | 150,466 | 193,069 |
| Net Cash Flow | $-258,282 | $317,146 | $316,826 | $-42,603 | $-46,328 |
| Free Cash Flow | |||||
| Operating Cash Flow | 753,447 | 520,638 | 243,499 | 178,468 | 276,274 |
| Capital Expenditure | -164,679 | -115,429 | -78,274 | -74,047 | -56,898 |
| Free Cash Flow | 588,768 | 405,209 | 165,225 | 104,421 | 219,376 |